• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS

Last Price$83.51Day Change (%)0.93%
Open Price$83.46Day Change ($)0.77
Day Range83.18–83.5852-Week Range69.90–104.75

As of Fri 7/22/2016 6:16:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

    Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

  2. Novartis Warns on Profit as Entresto Investment Weighs

    Novartis Warns on Profit as Entresto Investment Weighs

  3. Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis , Bayer - Research and Markets

    Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis , Bayer - Research and Markets

  4. Global Psoriasis Market Growth of 7.26% by 2024 - Analysis, Technologies & Forecasts Report 2016-2024 - Key Vendors: Johnson & Johnson, Novartis , Pfizer - Research and Markets

    Global Psoriasis Market Growth of 7.26% by 2024 - Analysis, Technologies & Forecasts Report 2016-2024 - Key Vendors: Johnson & Johnson, Novartis , Pfizer - Research and Markets

  5. Global Preventive Vaccines Market - Trends and Forecasts (2015-2020) - Expected to Reach USD 55 Billion - Research and Markets

    Global Preventive Vaccines Market - Trends and Forecasts (2015-2020) - Expected to Reach USD 55 Billion - Research and Markets

  6. China COPD Drugs Market Growth of 15.56% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AstraZeneca, GSK, Novartis - Research and Markets

    China COPD Drugs Market Growth of 15.56% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AstraZeneca, GSK, Novartis - Research and Markets

  7. Amgen Biosimilar Gets Thumbs-Up From FDA Panel

    Amgen Biosimilar Gets Thumbs-Up From FDA Panel

  8. Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 - Research and Markets

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 - Research and Markets

  9. Global Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) Pipeline Review 2016 - Research and Markets

    Global Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) Pipeline Review 2016 - Research and Markets

  10. Ovarian Cancer - Pipeline Insights, 2016 - Research and Markets

    Ovarian Cancer - Pipeline Insights, 2016 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.